FinancialGovernment SolutionsLegalReuters News AgencyRisk Management SolutionsTax & AccountingBlog: Answers OnInnovation @ Thomson Reuters
Directory of sites
Login
Contact
Support
Road to Brexit
Royal Family
The Trump Effect
Detained in Myanmar
North Korea Revealed
Science
Sport
Lifestyle
April 2, 2018 / 8:57 PM / 24 days ago

BRIEF-Precision Therapeutics Q4 Loss Per Share $0.43

Reuters Staff

1 Min Read

April 2 (Reuters) - Precision Therapeutics Inc:

* PRECISION THERAPEUTICS REPORTS FISCAL YEAR 2017 FINANCIAL RESULTS

* Q4 LOSS PER SHARE $0.43

* Q4 REVENUE $220,300 VERSUS $139,600 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

© 2018 Reuters. All Rights Reserved.